Navigation Links
SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
Date:12/22/2010

BOTHELL, Wash., Dec. 22, 2010 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc., a Delaware corporation ("SCOLR") (NYSE AMEX: DDD), today announced that it notified the NYSE Amex Exchange (the "Exchange") of its intent to file a Form 25 with the Securities and Exchange Commission (the "Commission") to effect the voluntary withdrawal of SCOLR's common stock from listing on the Exchange.  SCOLR plans to file the Form 25 with the Commission on or about January 3, 2011.  SCOLR expects that its common stock will cease trading on the Exchange upon the effectiveness of its withdrawal from listing, which will occur ten calendar days following the filing of a Form 25.  SCOLR anticipates that its common stock will begin quotation on the OTC Bulletin Board thereafter.

SCOLR is voluntarily withdrawing its common stock from listing on the Exchange because it has determined that it cannot reasonably expect to regain compliance with the Exchange's continued listing standards by December 27, 2010, the date of expiration of a compliance extension period afforded by the Exchange.  SCOLR believes that voluntary withdrawal will provide a more orderly transition of trading in its common stock to the OTC Bulletin Board or similar quotation service, and anticipates that its common stock will begin quotation on the OTC Bulletin Board after the effectiveness of withdrawal of its common stock from listing on the Exchange.

As previously disclosed, SCOLR was notified by the Exchange (i) that it was not in compliance with Section 1003(a)(iii) of the NYSE Amex Company Guide (the "Company Guide") because it had stockholders' equity of less than $6 million and losses from continuing operations and net losses in its five most recent fiscal years; and (ii) that it did not meet the continued listing standard set forth in Section 1003(a)(ii) of the Company Guide because it had stockholder
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
4. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
5. SCOLR Pharma, Inc. Licenses Dietary Supplements
6. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
7. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
8. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
9. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
10. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
11. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces ... available in its catalogue: Wireless ... RFID, Zigbee, UWB WWAN, WMAN, WLAN and ... Kalorama Information,s Wireless Opportunities ... Zigbee, UWB WWAN, WMAN, WLAN and other ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
(Date:8/20/2014)... LYNDHURST, N.J. , Aug. 20, 2014  Amerigen ... Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA ... Mecobalamin 0.5 mg Tablets into the ... of a marketing and distribution agreement with Sinochem ... product at its US FDA approved and China ...
Breaking Medicine Technology:Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 13Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 14Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 15Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 16Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... 27, 2011 Aethlon Medical, Inc. (OTCBB: AEMD), ... address infectious disease and cancer, disclosed today that ... "A Medical Device Strategy To Inhibit HER2+ Breast ... the company,s website at: http://www.aethlonmedical.com/assets/001/5080.pdf ...
... Sept. 27, 2011 BD Biosciences, a segment of ... of the new BD Falcon™ Multi-Flask, a multi-layer cell ... cell culture easily and more efficiently. ... flasks. The new BD Falcon Multi-Flask, available in both ...
Cached Medicine Technology:"A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc. 2"A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc. 3BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity 2
(Date:8/20/2014)... Angeldress.co.uk is one of the most ... It has earned the trust of thousands of consumers. ... pricing. Recently, it has unveiled its new designs of ... This time, the company offers more than 20 different ... products are offered at promotional prices (up to 60 ...
(Date:8/20/2014)... Park Avenue Dental, a leading Florida-based dental ... top graduate of the University of Detroit School of ... website through an ultra-informative blog focused on dental tips ... the blog page is chock full of topics that ... concentrating on important dental care tips including ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Ticket Down ... tickets in NYC. In just a week, the U.S. ... King Tennis Center. The event was originally founded in 1881 and ... Rafael Nadal was forced to withdrawal from the event because of ... women’s tournament and will return to New York City with hopes ...
(Date:8/20/2014)... 42 percent of women underwent breast reconstruction following ... with foregoing reconstruction included being black, having a ... Monica Morrow, M.D., of the Memorial Sloan Kettering ... The Women,s Health and Cancer Rights Act in ... a mastectomy. Still, most women who undergo a ...
(Date:8/20/2014)... 20, 2014 (HealthDay News) -- Pigs, hearts transplanted into ... twice as long as previously achieved, researchers report. ... to use animal organs to shorten transplant waiting lists. ... engineered piglets into baboons, abdomens. The genetic engineering and ... are what enabled the hearts to survive for more ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Now Dazzles With Beautiful Summer Cocktail Party Dresses 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2
... ... April 1 , ... (Vocus) March 16, 2010 -- Prodigy Diabetes Care, LLC, is launching its new Prodigy Count-a-dose™ ... , , , ,The Prodigy Count-a-dose™ offers diabetics a device which can easily measure and ...
... palliative care programs come too late, survey finds ... services, which help people who are seriously ill relieve ... U.S. cancer centers, but many programs don,t interact with ... , Dr. David Hui, of the University of Texas ...
... Franklin Goose is making a ... being free of harmful chemicals. They vow that if anything is purchased that does not meet ... over 1500 carefully vetted products for their babies & children, and even a few for the ... (PRWEB) March 16, 2010 ...
... PRINCETON, N.J. , March 16 Tickerspy ( ... Indexes, announced the creation of the Chinese Healthcare Stocks Index, ... AOB ), Sinovac Biotech (Nasdaq: SVA ), Mindray ... (Nasdaq: CMED ), WuXi PharmaTech (NYSE: WX ...
... that uses multiple radiation beams to target tumors precisely has ... improve survival rates for lung-cancer patients unable to undergo surgery, ... national clinical trial of the treatment. In a study ... of the American Medical Association, primary lung cancer did ...
... University study aimed at alleviating intestinal damage in trauma ... medication given to the individuals. Diana Hylton is ... She is analyzing how the immune system is involved ... studying the effects of a complement inhibitor given following ...
Cached Medicine News:Health News:Prodigy Re-Launches Syringe-Filling System for Blind and Low-Vision Diabetics 2Health News:Pain Relief Often Delayed for Cancer Patients 2Health News:Safe Baby Promise Offered by Franklin Goose 2Health News:Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks 2Health News:Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks 3Health News:Precision radiation therapy may improve survival rates of some lung cancer patients 2Health News:Study says therapeutics for trauma patients may not be effective due to an infection 2Health News:Study says therapeutics for trauma patients may not be effective due to an infection 3
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... The ProteomeLab XL-A/XL-I functions over a ... strength and pH, delivering more thorough ... operating methodology measures the relative change ... providing an efficient way to measure ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: